                               SEQUENCE LISTING

<110> Roche Diagnostics GmbH
      F. Hoffmann-La Roche AG
      Roche Molecular Systems, Inc.
 
<120> PHI6 INTERNAL CONTROL COMPOSITIONS, DEVICES & METHODS

<130> P33787-WO-HS

<150> 62/406,166
<151> 2016-10-10

<160> 3     

<170> PatentIn version 3.5

<210> 1
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      probe"

<400> 1
tgcgatccgt gtccaagggt tcgc                                              24


<210> 2
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 2
gcatttctgg agcagtgcat                                                   20


<210> 3
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 3
gactgccaag gtgccatta                                                    19


